WFS
SPPI

Widmann Financial Services’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Widmann Financial Services’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15
Closed – – 489
2021
Q4 		$0 Buy
+15
New +$27 ﹤0.01% 498

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return

Widmann Financial Services's SPPI Position: Q1 2022 in Review

Widmann Financial Services sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2022, closing a stake of 15 shares.

Widmann Financial Services first reported a position in SPPI in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 101 funds tracked by Wall St. Rank hold SPPI as of Q1 2022.

  • Widmann Financial Services reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • Widmann Financial Services sold 15 Spectrum Pharmaceuticals Inc shares in Q1 2022.
  • Widmann Financial Services first reported a position in Spectrum Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
  • Widmann Financial Services's Spectrum Pharmaceuticals Inc position peaked at $0 in Q4 2021.
  • 101 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2022.

Based on Widmann Financial Services's 13F filing for Q1 2022, filed 4 May 2022.